Lentiviral Vector Engineering

Lentiviral Vector Engineering is a methodological framework within ex vivo gene therapy that involves the design and modification of replication-deficient lentiviral vectors to achieve efficient, stable, and targeted integration of therapeutic transgenes into the host genome.

520

Publications

28.3K

Citations

3.4K

Authors

886

Institutions

Publications per year

2017–2026

123

Authors

3.4K

  1. AS
    Axel Schambach

    Medizinische Hochschule Hannover, Germany

    14 publications · 673 citations

    14

    h-index

  2. LN
    Luigi Naldini

    The San Raffaele Telethon Institute for Gene Therapy, Italy

    11 publications · 1.3K citations

    11

    h-index

  3. DB
    Donald B. Kohn

    Children's Hospital of Los Angeles, United States

    10 publications · 393 citations

    10

    h-index

  4. JJ
    John J. Rossi

    City of Hope, United States

    11 publications · 689 citations

    10

    h-index

  5. DT
    Didier Trono

    École Polytechnique Fédérale de Lausanne, Switzerland

    10 publications · 873 citations

    10

    h-index

1–5 of 3.4K

Venues

  1. Molecular Therapy

    48 publications · 3.3K citations

    33

    h-index

  2. Gene Therapy

    50 publications · 2.3K citations

    28

    h-index

  3. Blood

    32 publications · 3.1K citations

    26

    h-index

  4. Human Gene Therapy

    19 publications · 827 citations

    14

    h-index

  5. PLoS ONE

    15 publications · 889 citations

    14

    h-index

1–5